Overexpression of PID1 in human myoblasts results in reduced insulin signaling [31] which has been pointed out as a neuroprotective agent acting mainly against apoptosis, beta amyloid toxicity, oxidative stress, and ischemia [34]. The gene discussed is PID1; the disease is ischemia.